Assessment of patients' understanding of and adherence to oral anticancer medication (OAM): Results of a cross-sectional institutional pilot study.

Angie Mae RoddayDouglas HackenyosRaisa MasoodNicole SavidgeMingqian LinRuth Ann WeidnerSusan K Parsons

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

Understanding of OAM taking and handling in this group of vulnerable patients was low and did not align with patient-reported adherence. Future interventions should ensure that patients understand how to safely take and handle OAM, thereby optimizing their therapeutic potential.

Keyphrases

patient reported
ejection fraction
newly diagnosed
type diabetes
emergency department
metabolic syndrome
insulin resistance
glycemic control